10-97319519-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005479.4(FRAT1):āc.66G>Cā(p.Glu22Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00022 in 1,478,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005479.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRAT1 | NM_005479.4 | c.66G>C | p.Glu22Asp | missense_variant | 1/1 | ENST00000371021.5 | NP_005470.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRAT1 | ENST00000371021.5 | c.66G>C | p.Glu22Asp | missense_variant | 1/1 | 6 | NM_005479.4 | ENSP00000360060.3 |
Frequencies
GnomAD3 genomes AF: 0.00104 AC: 158AN: 151916Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000120 AC: 11AN: 91424Hom.: 0 AF XY: 0.0000394 AC XY: 2AN XY: 50748
GnomAD4 exome AF: 0.000124 AC: 164AN: 1326816Hom.: 0 Cov.: 31 AF XY: 0.000101 AC XY: 66AN XY: 654632
GnomAD4 genome AF: 0.00106 AC: 161AN: 152024Hom.: 0 Cov.: 32 AF XY: 0.00108 AC XY: 80AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.66G>C (p.E22D) alteration is located in exon 1 (coding exon 1) of the FRAT1 gene. This alteration results from a G to C substitution at nucleotide position 66, causing the glutamic acid (E) at amino acid position 22 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at